SEC 13F Intelligence

Bokf, Na / LLY

Bokf, Na’s Eli Lilly & Co Position

Does Bokf, Na own Eli Lilly & Co (LLY)? Yes — 51.5K shares worth $47M (+0.72% of its 13F portfolio) as of Q1 2026, down from 52.3K shares the prior filed quarter.

Position Value
$47M
Q1 2026
Shares
51.5K
% of Portfolio
+0.72%
Quarters Held
28
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $9MQ4 ’18Q1 ’19: $10MQ2 ’19: $6MQ3 ’19: $5MQ4 ’19: $5MQ4 ’19Q1 ’20: $6MQ2 ’20: $8MQ3 ’20: $11MQ4 ’20: $12MQ4 ’20Q1 ’21: $14MQ3 ’21: $13MQ1 ’22: $14MQ2 ’22: $16MQ2 ’22Q3 ’22: $23MQ4 ’22: $25MQ1 ’23: $22MQ2 ’23: $29MQ2 ’23Q3 ’23: $33MQ4 ’23: $33MQ1 ’24: $43MQ2 ’24: $51MQ2 ’24Q3 ’24: $51MQ4 ’24: $46MQ1 ’25: $47MQ2 ’25: $44MQ2 ’25Q3 ’25: $43MQ4 ’25: $56MQ1 ’26: $47Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202651.5K$47M+0.72%
Q4 202552.3K$56M+0.86%
Q3 202556.2K$43M+0.65%
Q2 202556.4K$44M+0.71%
Q1 202557.1K$47M+0.83%
Q4 202457.3K$46M+0.77%
Q3 202458.1K$51M+0.91%
Q2 202456.6K$51M+0.92%
Q1 202457.1K$43M+0.79%
Q4 202357.5K$33M+0.66%
Q3 202359.9K$33M+0.73%
Q2 202361.1K$29M+0.58%
Q1 202364.7K$22M+0.46%
Q4 202268.4K$25M+0.46%
Q3 202271.5K$23M+0.47%
Q2 202250.1K$16M+0.31%
Q1 202250.1K$14M+0.24%
Q3 202156.3K$13M+0.22%
Q1 202176.4K$14M+0.26%
Q4 202072.6K$12M+0.23%
Q3 202073.2K$11M+0.24%
Q2 202049.7K$8M+0.19%
Q1 202041.6K$6M+0.17%
Q4 201935.6K$5M+0.11%
Q3 201943.0K$5M+0.12%
Q2 201954.8K$6M+0.15%
Q1 201979.6K$10M+0.25%
Q4 201877.6K$9M+0.26%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bokf, Na’s full portfolio or all institutional holders of LLY.